Genotoxic and carcinogenic risk to humans of drug-nitrite interaction products

Mutation Research - Reviews in Mutation Research

Volumn 635, Issue 1, 2007, Pages 17-52

  Brambilla, Giovanni ^a   Martelli, Antonietta ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

Drug nitrite interaction products; Genotoxic and carcinogenic effects of N nitroso derivatives of drugs; Nitrosatable drugs

Indexed keywords

ACETOHEXAMIDE; ACETYLSPIRAMYCIN; AJMALINE; ALLOPURINOL; ALPRENOLOL; AMBROXOL; AMITRIPTYLINE; AMPICILLIN; ASCORBIC ACID; ATENOLOL; AZAPROPAZONE; BAMETHAN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BUTYLATED HYDROXYANISOLE; CHLORDIAZEPOXIDE; CIMETIDINE; DIMETOFRINE; NITRITE; NITROSO DERIVATIVE; OMEPRAZOLE; OPIPRAMOL; OXIDIZING AGENT; OXYTETRACYCLINE; PARACETAMOL; PHENAZONE; PIPERAZINE; SODIUM NITRITE; SULFANILAMIDE; TOLAZAMIDE; UNINDEXED DRUG; CARCINOGEN; MUTAGENIC AGENT;

CANCER RISK; CARCINOGENIC ACTIVITY; CHEMICAL REACTION; CHEMICAL STRUCTURE; CHEMISTRY; DRUG DETERMINATION; DRUG MECHANISM; EXPERIMENTAL STUDY; GENOTOXICITY; HUMAN; NITROSATION; NONHUMAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; ANIMAL; CHEMICALLY INDUCED DISORDER; DNA DAMAGE; DRUG EFFECT; DRUG INTERACTION; METABOLISM; NEOPLASM; STOMACH;

ANIMALIA;

ANIMALS; CARCINOGENS; DNA DAMAGE; DRUG INTERACTIONS; HUMANS; MUTAGENS; NEOPLASMS; NITRITES; NITROSATION; NITROSO COMPOUNDS; STOMACH;

EID: 33947600311     PISSN: 13835742     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrrev.2006.09.003     Document Type: Review

References (229)

1. Bogovski P., and Bogovski S. Animal species in which N-nitroso compounds induce cancer. Int. J. Cancer 27 (1981) 471-474
2. Schmähl D., and Scherf H.R. Carcinogenic activity of N-nitrosodiethylamine in snakes (Phython reticulatus, Schneider). In: O'Neill I.K., Von Bortsel R.C., Miller C.T., Long J., and Bartsch H. (Eds). N-Nitroso Compounds: Occurrence, Biological Effects and Relevance to Human Cancer, IARC Scientific Publications No. 57 (1984), International Agency for Research on Cancer, Lyon, France 677-682
3. Preussmann R., Spiegelhalder B., Eisenbrand G., and Janzowski C. N-nitroso compounds in food. In: Miller E.C., Miller J.A., Hirono I., Sugimura T., and Takayama S. (Eds). Naturally Occurring Carcinogens-Mutagens and Modulators of Carcinogenesis (1979), University Park Press, Baltimore, MD 185-194
4. Krull I.S., Edwards G., Wolf M.H., Fan T.Y., and Fine D.M. N-Nitrosamines in consumer products and in the workplace. Am. Chem. Soc. Symp. Ser. 101 (1979) 175-194
5. Hoffmann D., Adams J.D., Brunnemann K.D., and Hecht S.S. Assessment of tobacco-specific N-nitrosamines in tobacco products. Cancer Res. 39 (1979) 2505-2509
6. Lijinsky W. Significance of in vivo formation of N-nitroso compounds. Oncology 37 (1980) 223-226
7. International Agency for Research on Cancer (IARC), Monographs on the Evaluation of the Carcinogenic Risks to Humans, Supplement 7, Overall Evaluation of Carcinogenicity: An Updating of IARC Monographs, vol. 1-42, IARC, Lyon, France, 1987.
8. Lijinsky W., Conrad E., and Van de Bogart R. Formation of carcinogenic nitrosamines by interaction of drugs with nitrite. In: Bogovski P., Preussman R., and Walker E.A. (Eds). N-Nitroso Compounds Analysis and Formation, IARC Scientific Publications No. 3 (1972), International Agency for Research on Cancer, Lyon, France 130-133
9. Lijinsky W., and Greenblatt M. Carcinogen dimethylnitrosamine produced in vivo from nitrite and aminopyrine. Nat. New Biol. 236 (1972) 177-178
10. Lijinsky W., Conrad E., and Van de Bogart R. Carcinogenic nitrosamines formed by drug-nitrite interaction. Nature 239 (1972) 165-167
11. International Agency for Research on Cancer (IARC), Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans, vol. 24, Some Pharmaceutical Drugs, General Considerations on N-Nitrosatable Drugs, IARC, Lyon, France, 1980, pp. 297-314.
12. Müller L., Kikuchi Y., Probst G., Schechtman L., Shimada H., Sofuni T., and Tweats D. ICH-harmonised guidances on genotoxicity testing of pharmaceuticals: evolution, reasoning and impact. Mutat. Res. 436 (1999) 195-225
13. Brambilla G., and Martelli A. Keynote comment: nitrosatable drugs, cancer, and guidelines for genotoxicity. Lancet Oncol. 6 (2005) 538-539
14. Mirvish S.S. Formation of N-nitroso compounds: chemistry, kinetics and in vivo occurrence. Toxicol. Appl. Pharmacol. 31 (1975) 325-351
15. Smith P.A., and Loeppky R.N. Nitrosative cleavage of tertiary amines. J. Am. Chem. Soc. 89 (1967) 1147-1157
16. Lijinsky W., Keefer L., Conrad E., and Van de Bogart R. Nitrosation of tertiary amines and some biological implications. J. Natl. Cancer Inst. 49 (1972) 1239-1249
17. Mirvish S.S. The etiology of gastric cancer. Intragastric nitrosamides formation and other theories. J. Natl. Cancer Inst. 71 (1983) 629-647
18. Tannenbaum S.R., Sinskey A.J., Weisman M., and Bishop W. Nitrite in human saliva. Its possible relationship to nitrosamine formation. J. Natl. Cancer Inst. 53 (1974) 79-84
19. Mirvish S.S., Reimers K.J., Kutler B., Chen S.C., Haorah J., Morris C.R., Grandjean A.C., and Lyden E.R. Nitrate and nitrite concentrations in human saliva for men and women at different ages and times of the day and their consistency over time. Eur. J. Cancer Prev. 9 (2000) 335-342
20. Tannenbaum S.R., Fett D., Young V.R., Land P.D., and Bruce W.R. Nitrite and nitrate are formed by endogenous synthesis in the human intestine. Science 200 (1978) 1487-1489
21. Tannenbaum S.R., Young V.R., Green L., and Ruiz De Luzuriaga K. Intestinal formation of nitrite and N-nitrosocompounds. In: Walker E.A., Griciute L., Castegnaro M., and Bözzsöny M. (Eds). N-Nitroso Compounds: Analysis, Formation and Occurrence, IARC Scientific Publications No. 31 (1980), International Agency for Research on Cancer, Lyon, France 281-287
22. Reed P.I., Smith P.L., Haines K., House F.R., and Walters C.L. Gastric juice nitrosamines in health and gastroduodenal disease. Lancet 2 8246 (1981) 550-552
23. De Bernardinis G., Guadagni S., Pistoia M.A., Amicucci G., Masci C., Agnifili A., and Carboni M. Gastric juice nitrite and bacteria in gastroduodenal disease and resected stomach. Tumori 69 (1983) 231-237
24. Schlag P., Bockler R., and Peter M. Nitrite and nitrosamines in gastric juice: risk factors for gastric cancer?. Scand. J. Gastroenterol. 17 (1982) 145-150
25. Eisenbrand G., Adam B., Peter M., Malfertheiner P., and Schlag P. Formation of nitrite in gastric juice of patients with various gastric disorders after ingestion of a standard dose of nitrate-a possible risk factor in gastric carcinogenesis. In: O'Neill I.K., Von Borstel R.C., Miller C.T., Long J., and Bartsch H. (Eds). N-Nitroso Compounds: Occurrence, Biological Effects and Relevance to Human Cancer, IARC Scientific Publications No. 57 (1984), International Agency for Research on Cancer, Lyon, France 963-968
26. Hall C.N., Darkin D., Viney N., Cook A., Kirkham J.S., and Northfield T.C. Evaluation of the nitrosamine hypothesis of gastric carcinogenesis in man. In: Bartsch H., O'Neill I., and Schulte-Hermann R. (Eds). The Relevance of N-nitroso Compounds to Human Cancer, Exposures and Mechanisms, IARC Scientific Publications No. 84 (1987), International Agency for Research on Cancer, Lyon, France 527-530
27. Reed P.I., Smith P.L.R., Haines K., House F.R., and Walters C.L. Effect of cimetidine on gastric juice N-nitrosamine concentration. Lancet 2 8246 (1981) 553-556
28. Kyrtopoulos S.A., Daskalakis G., Legakis N.I., Konidaris N., Psarrou E., Bonatsos G., Golematis B., Lakiotis G., Bliouras N., and Outram J.R. Studies in gastric carcinogenesis. Part II. Absence of elevated concentrations of N-nitroso compounds in the gastric juice of Greek hypochlorhydric individuals. Carcinogenesis 6 (1985) 1135-1140
29. Kyrtopoulos S.A., Daskalakis G., and Outram J.R. Studies in gastric carcinogenesis. Part III. The kinetics of nitrosation of gastric juice components in vitro and their implication for the in vivo formation of N-nitroso compounds in normal and hypochlorhydric populations. Carcinogenesis 6 (1985) 1141-1145
30. Leach S.A., Thompson M., and Hill M. Bacterially catalysed N-nitrosation reactions and their relative importance in the human stomach. Carcinogenesis 8 (1987) 1907-1912
31. 1-nitrite reductase as one enzyme responsible for catalysis of nitrosation of secondary amines. Carcinogenesis 17 (1996) 533-536
32. Calmels S., Oshima H., and Bartsch H. Nitrosamine formation by denitrifying and non-denitrifying bacteria: implication of nitrite reductase and nitrate reductase in nitrosation catalysis. J. Gen. Microbiol. 134 (1988) 221-226
33. Ziebarth D., Spiegelhalder B., and Bartsch H. N-Nitrosation of medicinal drugs catalyzed by bacteria from human saliva and gastrointestinal tract, including Helicobacter pylori. Carcinogenesis 18 (1997) 383-389
34. Calmes S., Ohshima H., Vincent P., Gounot A.-M., and Bartsch H. Screening of microorganisms for nitrosation catalysis at pH 7 and kinetic studies on nitrosamine formation from secondary amines by E. coli strains. Carcinogenesis 6 (1985) 911-915
35. Calmels S., Bereziat J.C., Ohshima H., and Bartsch H. Bacterial formation of N-nitroso compounds from administered precursor in the rat stomach after omeprazole-induced achlorhydria. Carcinogenesis 12 (1991) 435-439
36. Calmes S., Bereziat J.C., Ohshima H., and Bartsch H. Bacterial formation of N-nitroso compounds in the rat stomach after omeprazole-induced achlorhydria. In: O'Neill I.K., Chen J., and Bartsch H. (Eds). Relevance to Human Cancer of N-nitroso Compounds, Tobacco Smoke and Mechanisms, IARC Scientific Publications No. 105 (1991), International Agency for Research on Cancer, Lyon, France 187-191
37. Hall C.N., Darkin D., Brimblecombe R., Cook A.J., Kirkham J.S., and Northfield T.C. Evaluation of nitrosamine hypothesis of gastric carcinogenesis in precancerous conditions. Gut 27 (1986) 491-498
38. Miwa M., Stuehr D.J., Marletta M.A., Wishnok J.S., and Tannenbaum S.R. Nitrosation of amines by stimulated macrophages. Carcinogenesis 8 (1987) 955-958
39. Ohshima H., and Bartsch H. Chronic infections and inflammatory processes as cancer risk factors: possible role of nitric oxide in carcinogenesis. Mutat. Res. 305 (1994) 253-264
40. Williams D.L. Nitrosating agents: is peroxynitrite a likely candidate ?. Nitric Oxide 1 (1997) 522-527
41. Mannick E.E., Bravo L.E., Zarama G., Realpe J.L., Zhang X.-J., Ruiz B., Fontham E.T.H., Mera R., Miller M.J.S., and Correa P. Inducible nitric oxide synthase, nitrotyrosine and apoptosis in Helicobacter pylori gastritis: effect of antibiotics and antioxidants. Cancer Res. 56 (1996) 3238-3243
42. Tsuji S., Kawano S., Tsujii M., Takei Y., Tanaka M., Sawaoka H., Nagano K., Fusamoto H., and Kamada T. Helicobacter pylori extract stimulates inflammatory nitric oxide production. Cancer Lett. 108 (1996) 195-200
43. Mirvish S.S., Babcook D.M., Deshpande A.D., and Nagel D.L. Identification of cholesterol as mouse skin lipid that reacts with nitrogen dioxide to yield a nitrosating agent, and of cholesteryl nitrite as the nitrosating agent produced in a chemical system from cholesterol. Cancer Lett. 31 (1986) 97-104
44. Mirvish S.S., Ramm M.D., Sams J.P., and Babcook D.M. Nitrosamine formation from amines applied to the skin of mice after and before exposure to nitrogen dioxide. Cancer Res. 48 (1988) 1095-1099
45. Boyland E., Nice E., and Williams K. The catalysis of nitrosation by thiocyanate from saliva. Food Cosmet. Toxicol. 9 (1971) 639-643
46. Licht W.R., and Deen W.M. Theoretical model for predicting rates of nitrosamine and nitrosamide formation in the human stomach. Carcinogenesis 9 (1988) 2227-2237
47. Davies R., Dennis M.J., Massey R.C., and McWeeny D.J. Some effects of phenol- and thiol-nitrosation reactions on N-nitrosamine formation. In: Walker E.A., Castegnaro M., Griciute L., and Lyle R.E. (Eds). Environmental Aspects of N-Nitroso Compounds, IARC Scientific Publications No. 19 (1978), International Agency for Research on Cancer, Lyon, France 183-197
48. Sottofattori E., Martelli A., and Brambilla G. The effect of benzenediols and benzenetriols on the nitrosation of propranolol depends on the position of hydroxyl groups on the benzene ring. Mutat. Res. 398 (1998) 75-82
49. Sottofattori E., Martelli A., and Brambilla G. Effects of mono-, di- and tri-hydroxybenzoic acids on the nitrosation of propranolol: structure-activity relationship. Mutat. Res. 490 (2001) 81-88
50. Brambilla G., Robbiano L., Cajelli E., Martelli A., Turmolini F., Mazzei M., and Cytotoxic. DNA-damaging and mutagenic properties of 2,6-dimethoxy-1,4-benzoquinone, formed by dimethophrine-nitrite interaction. J. Pharmacol. Exp. Ther. 244 (1988) 1011-1015
51. Bolker H.I., and Kung F.L. Formation of 2,6-dimethoxy-1,4-benzoquinone by the action of nitrous acid on 1,2,3-trimethoxybenzene. J. Chem. Soc. C (1969) 2298-2304
52. Mizuno M., Ohara A., Danno G., Kanazawa K., and Natake M. Mutagens formed from butylated hydroxyanisole treated with nitrite under acidic conditions. Mutat. Res. 176 (1987) 179-184
53. Endo H., Noda H., Kinoshita N., Inui N., and Nishi Y. Formation of a transplacental mutagen, 1,3-di(4-sulfamoylphenyl)triazene from sodium nitrite and sulfanilamide in human gastric juice and in the stomach of hamsters. J. Natl. Cancer Inst. 65 (1980) 547-551
54. Glatt H.R., Faigle J.W., and Oesch F. Tricyclic drugs: potent mutagenicity of traces of a nitroarene formed in the reaction of opipramol with nitrite. Mutat. Res. 190 (1987) 7-11
55. Harrington G.W., Eshraghi J., Pylypiw Jr. H.M., Kozeniauskas R., and Gillespie J.P. Formation of an N-nitrosamine by oxidation. Cancer Lett. 32 (1986) 187-191
56. Ohshima H., and Bartsch H. Quantitative estimation of endogenous nitrosation in humans by monitoring N-nitrosoproline excreted in the urine. Cancer Res. 41 (1981) 3658-3662
57. Knight T.M., Forman D., Ohshima H., and Bartsch H. Endogenous nitrosation of l-proline by dietary-derived nitrate. Nutr. Cancer 15 (1991) 195-203
58. Hall C.N., Kirkham J.S., and Northfield T.C. Urinary N-nitrosoproline excretion: a further evaluation of the nitrosamine hypothesis of gastric carcinogenesis in precancerous conditions. Gut 28 (1987) 216-220
59. Adam B., Schlag P., Friedl P., Preussmann R., and Eisenbrand G. Proline is not useful as chemical probe to measure nitrosation in the gastrointestinal tract of patients with gastric disorders characterized by anacidic conditions. Gut 30 (1989) 1068-1075
60. Ohshima H., Mahon G.A.T., Wahrendorf J., and Bartsch H. Dose-response study of N-nitrosoproline formation in rats and a deduced kinetic model for predicting carcinogenic effects caused by endogenous nitrosation. Cancer Res. 43 (1983) 5072-5076
61. Spiegelhalder B., and Preussmann R. In vivo nitrosation of amidopyrine in humans: use of 'ethanol effect' for biological monitoring of N-nitrosodimethylamine in urine. Carcinogenesis 6 (1985) 545-548
62. Webb K.S., Wood B.J., and Gough T.A. The effect of intake of a nitrosatable drug on the nitrosamine levels in human urine. Anal. Toxicol. 78 (1983) 181-184
63. Kumar R., Siddiqi M., Fazili Z., Wacker C.D., Spiegelhalder B., and Preussmann R. Effect of dietary nitrate on endogenous nitrosation of piperazine in humans. Cancer Lett. 65 (1992) 139-143
64. Tricker A.R., Kumar R., Siddiqi M., Khuroo M.S., and Preussmann R. Endogenous formation of N-nitrosamines from piperazine and their urinary excretion following antihelmintic treatment with piperazine citrate. Carcinogenesis 12 (1991) 1595-1599
65. Hecht S.S. Approaches to cancer prevention based on an understanding of N-nitrosamine carcinogenesis. Proc. Soc. Exp. Biol. Med. 216 (1997) 181-191
66. Druckrey H., Preussmann R., Ivankovic S., Schmähl D., Afkham J., Blum G., Mennel H.D., Müller M., Petropoulos P., and Schneider H. Organotrope carcinogene Wirkungen bei 65 verschiedenen N-Nitroso-Verbindungen an BD-Ratten. Z. Krebsforsch 69 (1967) 103-201
67. Magee P.N., and Barnes J.M. Carcinogenic nitroso compounds. Adv. Cancer Res. 10 (1967) 163-246
68. International Agency for Research on Cancer (IARC), Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans, vol. 17, Some N-Nitroso Compounds, IARC, Lyon, France, 1978.
69. International Agency for Research on Cancer (IARC), Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Humans, vol. 37, Tobacco Habits Other than Smoking: Betel-Quid and Areca-Nut Chewing; and Some Related Nitrosamines, IARC, Lyon, France, 1985.
70. Lijinsky W. Comparative carcinogenicity of N-nitroso compounds in different species. In: Walker E.A., Griciute L., Castegnaro M., and Börzsönyi M. (Eds). N-Nitroso Compounds: Analysis, Formation and Occurrence, IARC Scientific Publications No. 31 (1980), International Agency for Research on Cancer, Lyon, France 745-753
71. Preussmann R. Dose-response studies and "no-effect levels" of N-nitroso compounds: some general aspects. Oncology 37 (1980) 243-250
72. Bartsch H., and Montesano R. Relevance of nitrosamines to human cancer. Carcinogenesis 5 (1984) 1381-1393
73. Bartsch H., and O'Neill I.K. Eight international meeting on N-nitroso compounds. Occurrence, biological effects and relevance to human cancer. Cancer Res. 44 (1984) 1301-1304
74. Martelli A., Robbiano L., Gazzaniga G.M., and Brambilla G. Comparative study of DNA damage and repair induced by ten N-nitroso compounds in primary cultures of human and rat hepatocytes. Cancer Res. 48 (1988) 4144-4152
75. Robbiano L., Martelli A., Allavena A., Mazzei M., Gazzaniga G.M., and Brambilla G. Formation of the N-nitroso derivatives of six β-adrenergic-blocking agents and their genotoxic effects in rat and human hepatocytes. Cancer Res. 51 (1991) 2273-2279
76. Brambilla G., Robbiano L., Martelli A., Cajelli E., Allavena A., and Mazzei M. Genotoxicity of N-nitrosochlordiazepoxide in cultured mammalians cells. Toxicol. Appl. Pharmacol. 97 (1989) 480-488
77. Robbiano L., Mereto E., Corbu C., and Brambilla G. DNA damage induced by seven N-nitroso compounds in primary cultures of human and rat kidney cells. Mutat. Res. 368 (1996) 41-47
78. Robbiano L., Carrozzino R., Bacigalupo M., Corbu C., and Brambilla G. Correlation between induction of DNA fragmentation in urinary bladder cells from rats and humans and tissue-specific carcinogenic activity. Toxicology 179 (2002) 115-128
79. Montesano R., and Magee P.N. Metabolism of diethylnitrosamine by human liver slices in vitro. Nature 288 (1970) 173-174
80. Montesano R., and Magee P.N. Comparative metabolism in vitro of nitrosamines in various animal species including man. In: Montesano R., and Tomatis L. (Eds). Chemical Carcinogenesis Essays, IARC Scientific Publications No. 10 (1974), International Agency Research on Cancer, Lyon, France 39-56
81. Zatonski W., Oshima H., Przewozniak K., Drosik K., Mierzwinska J., Krygier M., Chmielarczyk W., and Bartsch H. Urinary excretion of N-nitrosamino acids and nitrate by inhabitants of high- and low-risk areas for stomach cancer in Poland. Int. J. Cancer 44 (1989) 823-827
82. Sierra R., Ohshima H., Muñoz N., Teuchmann S., Peña A.S., Malaveille C., Pignatelli B., Chinnoch A., El Ghissani F., Cheen C., Hautefeuille A., Gamboa C., and Bartsch H. Exposure to N-nitrosamines and other risk factors for gastric cancer in Costa Rican children. In: O'Neill I.K., Chen J., and Bartsch H. (Eds). Relevance to Human Cancer of N-nitroso Compounds, Tobacco Smoke and Mechanisms, IARC Scientific Publications No. 105 (1991), International Agency for Research on Cancer, Lyon, France 162-167
83. Stillwell W.G., Xu H.X., Glogowski J., Wishnok J.S., Tannenbaum S.R., and Correa P. Comparison of urinary nitrate, N-nitrosoproline, 7-methylyguanine and 3-methyladenine levels in a human population at risk for gastric cancer. In: O'Neill I.K., Chen J., and Bartsch H. (Eds). Relevance to Human Cancer of N-nitroso Compounds, Tobacco Smoke and Mechanisms, IARC Scientific Publications No. 105 (1991), International Agency for Research on Cancer, Lyon, France 83-87
84. Pignatelli B., Malaveille C., Rogato A., Hautefeuille A., Thuillier P., Munoz N., Moulinier B., Berger F., De Montclos H., Lambert R., and Mutagens. N-nitroso compounds and their precursors in gastric juice from patients with and without precancerous lesions of the stomach. Eur. J. Cancer. 29A (1993) 2031-2039
85. Xu G.P., So P.J., and Reed P.I. Hypothesis on the relationship between gastric cancer and intragastric nitrosation: N-nitrosamines in gastric juice of subjects from a high risks area for gastric cancer and the inhibition of N-nitrosamine formation by fruit juice. Eur. J. Cancer Prev. 2 (1993) 25-36
86. Sandor J., Kiss I., Farkas O., and Ember I. Association between gastric cancer mortality and nitrate content of drinking water: ecological study on small areas inequalities. Eur. J. Epidemiol. 17 (2001) 443-447
87. Shi K.X., Mao D.J., Cheng W.F., Ji Y.S., and Xu L.Z. An approach to establishing N-nitroso compounds as the cause of gastric cancer. In: O'Neill I.K., Chen J., and Bartsch H. (Eds). Relevance to Human Cancer of N-nitroso Compounds, Tobacco Smoke and Mycotoxins, IARC Scientific Publications No. 105 (1991), International Agency for Research on Cancer, Lyon, France 143-145
88. Knekt P., Jarvinen R., Dich J., and Hakulinen T. Risk of colorectal and other gastro-intestinal cancers after exposure to nitrate, nitrite, and N-nitroso compounds: a follow-up study. Int. J. Cancer 80 (1999) 852-856
89. Preston-Martin S., Yu M.C., Benton B., and Henderson B.E. N-Nitroso compounds and childhood brain tumors: a case-control study. Cancer Res. 42 (1982) 5240-5245
90. Burch J.D., Craib K.J.P., Choi B.C.K., Miller A.B., Risch H.A., and Howe G.R. An exploratory case-control study of brain tumors in adults. J. Natl. Cancer Inst. 78 (1987) 601-609
91. Olshan A.F., and Faustman E.M. Nitrosatable drug exposure during pregnancy and adverse pregnancy outcome. Int. J. Epidemiol. 18 (1989) 891-899
92. Carozza S.E., Olshan A.F., Faustman E.M., Gula M.J., Kolonel L.N., Austin D.F., West E.D., Weiss N.S., Swanson G.M., and Lyon J.L. Maternal exposure to N-nitrosatable drugs as a risk factor for childhood brain tumors. Int. J. Epidemiol. 24 (1995) 308-312
93. McKean-Cowdin R., Pogoda J.M., Lijinsky W., Holly E.A., Mueller B.A., and Preston-Martin S. Maternal prenatal exposure to nitrosatable drugs and childhood brain tumors. Int. J. Epidemiol. 32 (2003) 211-217
94. Cook M.N., Olshan A.F., Guess H.A., Savitz D.A., Poole C., Blatt J., Bondy M.L., and Pollock B.H. Maternal medication use and neuroblastoma in offspring. Am. J. Epidemiol. 159 (2004) 721-731
95. Gardner J.S., Guyard-Boileau B., Alderman B.W., Fernbach S.K., Green C., and Mangione E.J. Maternal exposure to prescription and non-prescription pharmaceuticals or drugs of abuse and risk of craniosynostosis. Int. J. Epidemiol. 27 (1998) 64-67
96. Croen L.A., Todoroff K., and Shaw G.M. Maternal exposure to nitrate from drinking water and diet and risk for neural tube defects. Am. J. Epidemiol. 153 (2001) 325-331
97. Brender J.D., Olive J.M., Felkner M., Suarez L., Marckwardt W., and Hendricks K.A. Dietary nitrites and nitrates, nitrosatable drugs, and neural tube defects. Epidemiology 15 (2004) 330-336
98. Ward M.H., Pan W.H., Cheng Y.J., Li F.H., Brinton L.A., Chen C.J., Hsu M.M., Chen I.H., Levine P.H., Yang C.S., and Hildesheim A. Dietary exposure to nitrite and nitrosamines and risk of nasopharyngeal carcinoma in Taiwan. Int. J. Cancer 86 (2000) 603-609
99. Risch H.A. Etiology of pancreatic cancer, with a hypothesis concerning the role of N-nitroso compounds and excess gastric acidity. J. Natl. Cancer Inst. 95 (2003) 948-960
100. Bartsch H., Ohshima H., Pignatelli B., and Calmels S. Human exposure to endogenous N-nitroso compounds: quantitative estimation in subjects at high risk for cancer of the oral cavity oesophagus, stomach and urinary bladder. Cancer Surv. 8 (1989) 335-362
101. Bartsch H., Ohshima H., Shuker D.E., Pignatelli B., and Calmels S. Exposure of humans to endogenous N-nitroso compounds: implications in cancer etiology. Mutat. Res. 238 (1990) 255-267
102. Wu Y., Chen J., Ohshima H., Pignatelli B., Borchman J., Li J., Campbell T.C., Peto R., and Bartsch H. Geographic association between urinary excretion of N-nitroso compounds and oesophageal cancer mortalità in China. Int. J. Cancer. 54 (1993) 713-719
103. WHO, Informal consultation on the potential carcinogenicity of nitrosatable drugs, in: Proceedings of the Report of a WHO Meeting, Geneva, June 12-16, 1978.
104. Scheunig G., and Ziebarth D. Formation of nitrosamines by interaction of some drugs with nitrite in human gastric juice. In: Walker E.A., Bogovski P., and Griciute L. (Eds). Environmental N-Nitroso Compounds Analysis and Formation, IARC Scientific Publications No. 14 (1976), International Agency for Research on Cancer, Lyon, France 269-277
105. Schmid J., Danek K., Koss F.W., Eisenbrand G., and Schlemmer K.H. Kinetic and analytic investigations on the formation of N-nitroso-N-methyl-N-cyclohexylamine from bromhexine and nitrite. Arzneimittel-Forsch. 38 (1988) 1355-1358
106. Schmid J., Bauer E., Danek K., Franke H., and Koss F.W. Lack of detectable N-nitroso-N-methyl-N-cyclohexylamine in humans after administration of bromhexine. Arzneimittel-Forsch. 38 (1988) 1359-1364
107. Schlemmer K.H., and Eisenbrand G. Nitrosation of bromhexine and aminophenazone in gastric juice after high nitrate loading in the diet. An ex-vivo/in vitro study in humans. Arzneimittel-Forsch. 38 (1988) 1365-1368
108. Ohta T., Oribe H., Kameyama T., Goto Y., and Takitani S. Formation of a diazoquinone-type mutagen from acetaminophen treated with nitrite under acidic conditions. Mutat. Res. 209 (1988) 95-98
109. Brambilla G., Cajelli E., Finollo R., Maura A., Pino A., and Robbiano L. Formation of DNA-damaging nitroso compounds by interaction of drugs wit nitrite. A preliminary screening for detecting potentially hazardous drugs. J. Toxicol. Environ. Health 15 (1985) 1-24
110. Sakai A., Inoue T., and Tanimura A. Formation of volatile nitrosamines by drug-nitrite interactions under physiological conditions. Gann 75 (1984) 245-252
111. Kikugawa K., Kato T., and Takeda Y. Formation of a highly mutagenic diazo compound from the bamethan-nitrite reaction. Mutat. Res. 177 (1987) 35-43
112. Lijinsky W. Reaction of drugs with nitrous acid as a source of carcinogenic nitrosamines. Cancer Res. 34 (1974) 255-258
113. Ziebarth D. Nitrosierbare Arzneimittel. Arch. Geschwulstforsch. 51 (1981) 587-595
114. Rao G.S., and Krishna G. Drug-nitrite interactions: formation of N-nitroso, C-nitroso, and nitro compounds from sodium nitrite and various drugs under physiological conditions. J. Pharm. Sci. 64 (1975) 1579-1581
115. Takeda Y., and Kanaya H. Formation of nitroso compounds and mutagens from cinnarizine, ethambutol, piromidic acid, pyridinol carbamate and tiaramide by drug/nitrite interaction. Cancer Lett. 15 (1982) 53-59
116. Ziebarth D., and Teichmann B. Nitrosation of orally administered drugs under simulated stomach conditions. In: Walker E.A., Griciute L., Castegnaro M., and Börzsönyi H. (Eds). N-Nitroso Compounds: Analysis, Formation and Occurrence, IARC Scientific Publications No. 31 (1980), International Agency for Research on Cancer, Lyon, France 231-244
117. Ziebarth D. Bildung flüchtinger kanzerogener N-Nitrosoverbindungen aus Arzneimitteln unter simulierten Bedingungen des menschlichen Magens. Arch. Geschwulstforsch. 55 (1985) 315-326
118. Ziebarth D. Vergleichende Untersuchungen des Nitrosierungverhaltens von Arzneimitteln bei konstanten pH-Wert und unter simulierten Magenbedingungen. Arch. Geschwulstforsch. 52 (1982) 429-442
119. Walters C.L., Gillatt P.N., Palmer R.C., Smith P.L.R., and Reed P.I. Nitrosation of drugs under in-vivo conditions. In: Bartsch H., O'Neill I., and Shultz-Hermann R. (Eds). The Relevance of N-nitroso Compounds to Human Cancer, Exposure and Mechanism, IARC Scientific Publication No. 84 (1987), International Agency for Research on Cancer, Lyon, France 351-354
120. Gillatt P.N., Hart R.J., Walters C.L., and Reed P.I. Susceptibilities of drugs to nitrosation under standardized chemical conditions. Food Chem. Toxicol. 22 (1984) 269-274
121. Gillat P.N., Palmer R.C., Smith P.L.R., Walters C.L., and Reed P.I. Susceptibilities of drugs to nitrosation under simulated gastric conditions. Food Chem. Toxicol. 23 (1985) 849-855
122. Lijinsky W. Formation of nitrosamines from tertiary amines and related compounds. Proc. Am. Assoc. Cancer Res. 13 (1972) 68
123. Arriaga Alba M., Espinosa J., and Cortinas de Nava C. Mutagenicity of products generated by the reaction between several antiparasitic drugs and nitrite. Environ. Mol. Mutagen. 12 (1988) 65-73
124. Takeda Y., and Kanaya H. Formation of nitroso compounds and mutagens from tranquilizers by drug/nitrite interaction. Cancer Lett. 12 (1981) 81-86
125. Schlemmer K.H., and Eisenbrand G. In-vitro and in-vivo formation of N-nitrosomethylcyclohexylamine from bromhexine and sodium nitrite in rats. In: Bartsch H., O'Neill I., and Schulte-Hermann R. (Eds). The Relevance of N-Nitroso Compounds to Human Cancer, Exposure and Mechanisms, IARC Scientific Publications No. 84 (1987), International Agency for Research on Cancer, Lyon, France 355-359
126. Ziebarth D., Schramm T., and Töppel A. Unter simulierten Bedingungen des menschlichen Magens nitrosierbare Arzneimittel den Gruppen der trizyklischen Antidepressiva und Antiepileptika. Arch. Geschwulstforsch. 59 (1989) 257-263
127. Mazzei M., Balbi A., Roma G., Di Braccio M., and Robbiano L. HPLC analysis of the nitrosation products of chlordiazepoxide. Farmaco-Ed. Sci. 44 (1989) 883-891
128. Kinawi A., Onken A., Rozyczka B., and König W. Untersuchungen zur Nitrosierbarkeit von Chlordiazepoxid unter physiologischen Bedingungen. Arzneimittel-Forsch. 27 (1977) 363-367
129. Röper H., and Heyns K. Possible nitrosodimethylamine formation in comparative in vitro nitrosation experiments with six different tetracycline antibiotics. In: Walker E.A., Castegnaro M., Griciute L., and Lyle R.E. (Eds). Environmental Aspects of N-Nitroso Compounds, IARC Scientific Publications No. 19 (1978), International Agency for Research on Cancer, Lyon, France 219-237
130. Anderson L.M., Giner-Sorolla A., Haller I.M., and Budinger J.M. Effects of cimetidine, nitrite, cimetidine plus nitrite, and nitrosocimetidine on tumors in mice following transplacental plus chronic lifetime exposure. Cancer Res. 45 (1985) 3561-3566
131. A. Martelli, C. Garbero, M. Gosmar, G. Brambilla, Formation of DNA-damaging N-nitroso derivatives from calcium channel antagonists by interaction with nitrite, Toxicology, submitted for publication.
132. Mazzei M., Roma G., Balbi A., Sottofattori E., and Robbiano L. Formation of 2,6-dimethoxy-1,4-benzoquinone, a highly genotoxic compound, from the reaction of sodium nitrite with the sympathomimetic drug dimethophrine in acidic aqueous solution, Il. Farmaco-Ed. Sci. 43 (1988) 523-538
133. Kikugawa K., Kato T., and Tukeda Y. Formation of a direct mutagen, diazo-N-nitrosoetilefrin, by interaction of etilefrin with nitrite. Chem. Pharm. Bull. 37 (1989) 1600-1603
134. Bae J.Y., Mende P., Shevlin G., Spiegelhalder B., Preussmann R., and Loeppky R.N. The nitrosation of hexetidine and hexedine: characterization of the major nitrosamine from common antimicrobial agents. Chem. Res. Toxicol. 7 (1994) 868-876
135. Gold B., and Mirvish S.S. N-Nitroso derivatives of hydrochlorothiazide, niridazole, and tolbutamide. Toxicol. Appl. Pharmacol. 40 (1977) 131-136
136. Shimizu H., Takemura N., Ando H., Morita M., and Machida K. Mutagenic activity of N-nitrosomethamphetamine and N-nitrosoephedrine. Cancer Lett. 21 (1983) 63-68
137. Mergens W.J., Vane F.M., Tannenbaum S.R., Green L., and Skipper P.L. In vitro nitrosation of methapyrilene. J. Pharm. Sci. 68 (1979) 827-832
138. Mirvish S.S., Wallcave L., Eagen M., and Shubik P. Ascorbate-nitrite reaction: possible means of blocking the formation of carcinogenic N-nitroso compounds. Science 177 (1972) 65-67
139. Eisenbrand G., and Preussmann R. Nitrosation of phenacetin. Formation of N-nitroso-2-nitro-4-ethoxyacetanilide as an unstable product of the nitrosation in dilute aqueous-acidic solution. Arzneimittel-Forsch. 25 (1975) 1472-1475
140. Chen J., and Raisfeld-Danse I.H. Drug interactions. Part II. Formation of nitrosamines from therapeutic drugs. Properties and kinetics of the formation of N-nitrosopropranolol from nitrite and the secondary amine propranolol hydrochloride. J. Pharmacol. Exp. Ther. 225 (1983) 705-712
141. Raisfeld-Danse I.H., and Chen J. Drug interactions. Part III. Formation of nitrosamines from therapeutic drugs. Formation, mutagenic properties and safety assessment of propranolol hydrochloride with respect to the intragastric formation of N-nitrosopropranolol under conditions found in patients. J. Pharmacol. Exp. Ther. 225 (1983) 713-719
142. Sottofattori E., Anzaldi M., Balbi A., and Martelli A. High-performance liquid chromatographic study of formation of N-nitrosopropranolol in simulated gastric juice, Il. Farmaco-Ed. Sci. 52 (1997) 123-125
143. Brambilla G., Martelli A., and Sottofattori E. Nitrosation of propranolol under simulated gastric conditions. Carcinogenesis 16 (1995) 1239-1242
144. Kanaya H., and Takeda Y. N-Mononitrosopyridinol carbamate: the principal mutagen formed by nitrosation of pyridinol carbamate. Cancer Lett. 18 (1983) 143-148
145. Maura A., Pino A., Robbiano L., Cajelli E., Finollo R., Cavanna M., and Brambilla G. DNA damage induced by nitrosated ranitidine in cultured mammalian cells. Toxicol. Lett. 18 (1983) 97-102
146. Hoogenboom L.A.P., Van Der Steeg P.W., Kuiper H.A., and Kramers P.G.N. In vitro formation of a triazene compound by reaction of sulphadimidine and nitrite. Food Chem. Toxicol. 25 (1987) 373-377
147. Greenblatt M., Mirvish S., and So B.T. Nitrosamine studies: induction of lung adenomas by concurrent administration of sodium nitrite and secondary amines in Swiss mice. J. Natl. Cancer Inst. 46 (1971) 1029-1034
148. Lijinsky W., and Taylor H.W. Carcinogenicity tests of N-nitroso derivatives of two drugs, phenmetrazine and methylphenidate. Cancer Lett. 1 (1976) 359-363
149. Lijinsky W., Taylor H.W., Snyder C., and Nettesheim P. Malignant tumors of liver and lung in rats fed aminopyrine or heptamethyleneimine with nitrite. Nature 244 (1973) 176-178
150. Taylor H.W., and Lijinsky W. Tumour induction in rats by feeding aminopyrine or oxytetracycline with nitrite. Int. J. Cancer 16 (1975) 211-215
151. Lijinsky W., and Reuber M.D. Tumors induced in Fisher 344 rats by feeding of disulfiram together with sodium nitrite. Food Cosmet. Toxicol. 18 (1980) 85-87
152. Lijinsky W., and Taylor H.W. Feeding test in rats on mixtures of nitrite with secondary and tertiary amines of environmental importance. Food Cosmet. Toxicol. 15 (1977) 269-274
153. Lijinsky W., and Taylor H.W. Nitrosamines and their precursors in food. In: Hiatt H.H., Watson J.D., and Winsten J.A. (Eds). Origins of Human Cancer, Book C, Human Risk Assessment (1977), Cold Spring Harbor Laboratory 1579-1590
154. Schneider J., Warzok R., and Schwarz H. Endogenous formation of carcinogenic N-nitroso compounds in rats after application of drugs and nitrite. Exp. Pathol. 13 (1977) 32-43
155. Özhan G., and Alpertunga B. Genotoxic activities of drug-nitrite interaction products. Drug. Chem. Toxicol. 26 (2003) 295-308
156. Andrews A.W., Lijinsky W., and Snyder S.W. Mutagenicity of amine drugs and their products of nitrosation. Mutat. Res. 135 (1984) 105-108
157. Andrews A.W., Fornwald J.A., and Lijinsky W. Nitrosation and mutagenicity of some amine drugs. Toxicol. Appl. Pharmacol. 52 (1980) 237-244
158. Boido V., Bennicelli C., Zanacchi P., and De Flora S. Formation of mutagenic derivatives from nitrite and two primary amines. Toxicol. Lett. 6 (1980) 379-383
159. Braun R., Schoneich J., and Ziebarth D. Testing of drugs for combined mutagenesis with sodium nitrite in the host-mediated assay. Arch. Toxicol. 4 Suppl. (1980) 49-53
160. Parodi S., Taningher M., Pala M., Brambilla G., and Cavanna M. Detection by alkaline elution of rat liver DNA damage induced by simultaneous subacute administration of nitrite and aminopyrine. J. Toxicol. Environ. Health 6 (1980) 167-174
161. Thamavit W., Moore M.A., Hiasa Y., and Ito N. Generation of high yields of Syrian hamster cholangiocellular carcinomas and hepatocellular nodules by combined nitrite and aminopyrine administration and Opisthorchis viverrini infection. Jpn. J. Cancer Res. 79 (1988) 909-916
162. Inui N., Nishi Y., and Tanimura A. Induction of 8-azaguanine-resistant mutation and neoplastic transformation of hamster embryonic cells by coadministration of sodium nitrite and aminopyrine. In: Bartsh H., O'Neill I.K., Castegnaro M., and Okada M. (Eds). N-Nitroso Compounds: Occurrence and Biological Effects, IARC Scientific Publications No. 41 (1982), International Agency for Research on Cancer, Lyon, France 585-590
163. Kawanishi T., Ohno Y., Sunouchi M., Onoda K., Takahashi A., Kasuya Y., and Omori Y. Studies on nitrosamine formation by the interaction between drugs and nitrite. Part II. Hepatotoxicity by the simultaneous administration of several drugs and nitrite. J. Toxicol. Sci. 6 (1981) 271-286
164. Farmer P.B., Shuker D.E.G., and Bird I. DNA and protein adducts as indicators of in vivo methylation by nitrosatable drugs. Carcinogenesis 7 (1986) 49-52
165. Gombar C.T., Zubrtoff J., Straham G.D., and Magee P.N. Measurement of 7-methylguanine as an estimate of the amount of dimethylnitrosamine formed following administration of aminopyrine and nitrite to rats. Cancer Res. 43 (1983) 5077-5080
166. Parisi D.M., and Rao G.S. Mutagenicity of 4-aminoantipyrine and 4-nitrosoantipyrine, the C-nitroso derivative of antipyrine. Mutat. Res. 206 (1988) 317-326
167. Martelli A., Allavena A., Sottofattori E., and Brambilla G. Low clastogenic activity in vivo of the N-nitrosoderivatives of 5 β-adrenergic-blocking drugs proved to be potent genotoxins in vitro. Toxicol. Lett. 73 (1994) 185-191
168. Arriaga Alba M., Espinosa Aguirre J., Ramirez J., and Cortinas de Nava C. Mutagenicity of urine from mice exposed orally to nitrite and various aminated antiparasitic drugs. Environ. Mol. Mutagen. 14 (1989) 13-19
169. Farmer P.B., Parry A., Franke H., and Schmid J. Lack of detectable DNA alkylation for bromhexine in man. Arzneimittel-Forsch. 38 (1988) 1351-1354
170. Erdinger L., Schmezer P., Razdan R., Kumar R., Spiegelhalder B., Preussmann R., and Siddiqi M. Caffeine-derived N-nitroso compounds. Part III. Mutagenicity in S. typhimurium and in vitro induction of DNA single-strand breaks in rat hepatocytes by mononitrosocaffeidine and dinitrosocaffeidine. Mutat. Res. 292 (1993) 41-49
171. Ivankovic S., Seibel J., Komitowski D., Spiegelhalder B., Preussmann R., and Siddiqi M. Caffeine-derived N-nitrosocompounds. Part V. Carcinogenicity of mononitrosocaffeidine and dinitrosocaffeidine in bd-ix rats. Carcinogenesis 19 (1998) 933-937
172. Krafft S., and Onken A. Induction of mitotic gene conversion in Saccharomyces cerevisiae with chlordiazepoxide and its N-nitroso derivative in a host-mediated assay. Mutat. Res. 34 (1976) 333-336
173. Robbiano L., Carlo P., Finollo R., and Brambilla G. DNA damage induced in rats by oral administration of chlordiazepoxide plus sodium nitrite or of N-nitroso chlordiazepoxide. Toxicol. Appl. Pharmacol. 102 (1990) 186-190
174. Giner-Sorolla A., Greenbaum J., Last-Barney K., Anderson L.M., and Budinger J.M. Lack of carcinogenic effect of nitrosochlordiazepoxide and nitrosomethylphenidate given orally to mice. Food. Cosmet. Toxicol. 18 (1980) 81-83
175. De Flora S., and Picciotto A. Mutagenicity of cimetidine in nitrite-enriched human gastric juice. Carcinogenesis 1 (1980) 925-930
176. Pool B.L., and Eisenbrand G. Biological activity of nitrosated cimetidine. Mutat. Res. 74 (1980) 243
177. Schwarz M., Hummel J., and Eisenbrand G. Induction of DNA strand breaks by nitrosocimetidine. Cancer Lett. 10 (1980) 223-228
178. Barrows L.R., Gombar C.T., Magee P.N., and Mutation. DNA labelling and transformation of BHK-21/CL13 cells by MNNG, and nitrosocimetidine. Mutat. Res. 102 (1982) 145-158
179. Athanasiou K., and Kyrtopoulos S.A. Induction of sister chromatid exchanges and chromosome aberrations in cultured mammalian cells by N-nitrosocimetidine. Cancer Lett. 14 (1981) 71-75
180. Ichinotsubo D., MacKinnon E.A., Liu C., Rice S., and Mower H.F. Mutagenicity of nitrosated cimetidine. Carcinogenesis 2 (1981) 261-264
181. Henderson E.E., Basilio M., and Davis R.M. Cellular DNA damage by nitrosocimetidine: a comparison with N-methyl-N′-nitroso-nitrosoguanidine and X-irradiation. Chem. Biol. Interact. 38 (1981) 87-98
182. Inoue K., Shibata T., Kosaka H., Uozumi M., Tsuda S., and Abe T. Induction of sister-chromatid exchanges by N-nitrosocimetidine in cultured human lymphocytes and its inhibition by chemical compounds. Mutat. Res. 156 (1985) 117-121
183. Brambilla G., Cavanna M., Maura A., Pino A., Robbiano L., Carlo P., Biassoni F., and Ricci R. Absence of DNA damage in liver of rats given high doses of cimetidine and sodium nitrite. J. Pharmacol. Exp. Ther. 221 (1982) 222-227
184. Pino A., and Robbiano L. Absence of DNA fragmentation in gastric mucosa of rats treated with high doses of cimetidine and nitrite. IRCS Med. Sci. 11 (1983) 172
185. Lijinsky W., and Reuber M.D. Comparison of nitrosocimetidine with nitrosomethylnitroguanidine in chronic feeding tests in rats. Cancer Res. 44 (1984) 447-449
186. Habs M., Eisenbrand G., Habs H., and Schmahl D. No evidence of carcinogenicity of N-nitrosocimetidine in rats. Hepatogastroenterology 29 (1982) 265-266
187. Jensen D.E., and Magee P.N. Methylation of DNA by nitrosocimetidine in vitro. Cancer Res. 41 (1981) 230-236
188. 6-methylguanine in rat DNA following in vivo treatment with large doses of cimetidine alone or in combination with sodium nitrite. Cancer Res. 42 (1982) 1962-1966
189. Jensen D.E. Denitrosation as a determinant of nitrosocimetidine in vivo activity. Cancer Res. 43 (1983) 5258-5267
190. Gombar C.T., and Magee P.N. DNA-methylation by nitrosocimetidine and N-methyl-N′nitro-N-nitrosoguanidine in the intact rat. Chem. Biol. Interact. 40 (1982) 149-157
191. Ono-Ogata T., Ogino T., Nishikawa M., Ohta T., and Yamagata H. Mutagenic activity and mutational specificity of antiprotozoal drugs with and without nitrite treatment, Environ. Mol. Mutagen. 39 (2002) 43-48
192. Sakai A., Yoshikawa K., Tanimura A., and Tomita I. Mutagenicity of reaction products of sulpyrine with nitrite. Mutat. Res. 90 (1981) 57-65
193. Changhao S., Bingquing C., Suyan W., and Zicheng L. Mutagenic activity of dopamine after nitrosation. Mutat. Res. 347 (1995) 17-19
194. Wogan G.N., Paglialunga S., Archer M.C., and Tannenbaum S.R. Carcinogenicity of nitrosation products of ephedrine, sarcosine, folic acid, and creatinine. Cancer Res. 35 (1975) 1981-1984
195. Eisenbrand G., Preussmann R., and Schmahl D. Carcinogenicity of N-nitrosoephedrine in rats. Cancer Lett. 5 (1978) 103-106
196. De Flora S., Camoirano A., Basso C., Astengo M., Zanacchi P., and Bennicelli C. Bacterial genotoxicity of nitrosated famotidine. Mutagenesis 1 (1986) 125-130
197. Kammerer R.C., Froines J.R., and Price T. Mutagenicity studies of select anthistamines, their metabolites and products of nitrosation. Food Chem. Toxicol. 24 (1986) 981-985
198. Martelli A., Canonero R., Allavena A., Sottofattori E., and Brambilla G. In vitro and in vivo evaluation of the genotoxicity of N-nitrosooxprenolol. Pharmacol. Toxicol. 70 (1992) 1-6
199. Lin J.-K., Yen J.-Y., Chang H.-W., and Lin-Shiau S.-Y. N-nitrosophenacetin: its synthesis, characterisation, mutagenicity, and teratogenicity. J. Natl. Cancer Inst. 72 (1984) 863-869
200. McCoy E.C., Rosenkranz H.S., and Bartsch H. Mutagenicity of phenacetin metabolites: N-hydroxy-phenetidine and nitrosophenetol in S. typhimurium TA100 and derivatives deficient in nitroreductase, or O-acetylase: probes for testing intrabacterial metabolic activation. Mutat. Res. 173 (1986) 245-250
201. Li S.Y., and Lin J.K. Sequential monitoring of cytogenetic damage in rat lymphocytes following in vivo exposure to aflatoxin B1 and N-nitrosophenacetin. Mutat. Res. 242 (1990) 219-224
202. Greenblatt M., and Mirvish S.S. Dose-response studies with concurrent administration of piperazine and sodium nitrite to strain A mice. J. Natl. Cancer Inst. 50 (1973) 119-124
203. Borzsonyi M., Török G., Pinter A., Surján A., Nádasdi L., and Roller P. Carcinogenic effect of dinitrosopiperazine in adult Suiss mice and after transplavcental or translactational exposure. Cancer Res. 40 (1980) 2925-2927
204. Lijinsky W., and Kovatch R.M. Carcinogenic effects in rats of nitrosopiperazines administered intravescically: possible implications for the use of piperazine. Cancer Lett. 74 (1993) 101-103
205. De Flora S., Bennicelli C., Camoirano A., and Zanacchi P. Genotoxicity of nitrosated ranitidine. Carcinogenesis 4 (1983) 255-260
206. Franekic J., Skupnjak S., and Matijasevic Z. Genotoxicity of nitrosated ranitidine. Mutat. Res. 227 (1989) 13-16
207. Martelli A., Fugassa E., Voci A., and Brambilla G. Unscheduled DNA synthesis induced by nitrosated ranitidine in primary cultures of rat hepatocytes. Mutat. Res. 122 (1983) 373-376
208. Brambilla G., Cavanna M., Faggin P., Maura A., Pino A., Ricci R., and Robbiano L. Genotoxic effectsin rodents given high oral doses of ranitidine and sodium nitrite. Carcinogenesis 4 (1983) 1281-1285
209. Kasamaki A., and Urasawa S. Induction of mutagenic activity of tetracycline by synergistic action with nitrite. J. Toxicol. Sci. 12 (1987) 73-85
210. Bartsch H., Ohshima H., and Pignatelli B. Inhibitors of endogenous nitrosation. Mechanisms and implications in human cancer prevention. Mutat. Res. 202 (1988) 307-324
211. Kyrtopoulos S.A., Pignatelli B., Karkanias G., Golematis B., and Esteve J. Studies in gastric carcinogenesis. Part V. The effect of ascorbic acid on N-nitroso compound formation in human gastric juice in vivo and in vitro. Carcinogenesis 12 (1991) 1371-1376
212. Mackerness C.W., Leach S.A., Thompson M.H., and Hill M.J. The inhibition of bacterially mediated N-nitrosation by Vitamin C: relevance to the inhibition of endogenous N-nitrosation in the achlorhydric stomach. Carcinogenesis 10 (1989) 397-399
213. Leaf C.D., Vecchio A.J., Roe D.A., and Hotchkiss J.H. Influence of ascorbic acid dose on N-nitrosoproline formation in humans. Carcinogenesis 8 (1987) 791-795
214. Ziebarth D., and Schramm T. Wirkung einiger nichttoxiocher Inhibitoren auf die Nitrosierung von Arzneimitteln under simulierten Bedingungen des menschlichen Magens. Arch. Geschwulstforsch. 55 (1985) 81-89
215. Mirvish S.S. Experimental evidence for inhibition of N-nitroso compound formation as a factor in the negative correlation between Vitamin C consumption and the incidence of certain cancers. Cancer Res. 54 Suppl. 7 (1994) 1948-1951
216. Mirvish S.S. Effects of Vitamins C and E on N-nitroso compound formation, carcinogenesis, and cancer. Cancer 58 Suppl. 8 (1986) 1842-1850
217. Tanaka K., Hayatsu T., Negishi T., and Hayatsu H. Inhibition of N-nitrosation of secondary amines in vitro by tea extracts and catechins. Mutat. Res. 412 (1998) 91-98
218. Shendrikova I.A., Ermilov V.B., and Dikun P.P. The influence of ethanol on synthesis of N-nitrosodimethylamine in vivo and in vitro. Cancer Lett. 25 (1984) 49-54
219. Gichner T., and Veleminský J. Mechanisms of inhibition of N-nitroso compounds-induced mutagenicity. Mutat. Res. 202 (1988) 325-334
220. Gichner T., and Veleminský J. Inhibitors of N-nitroso compounds-induced mutagenicity. Mutat. Res. 195 (1988) 21-43
221. Cai H.Y. Retinoids prevent epithelial carcinogenesis induced by N-nitroso compounds. In: O'Neill I.K., Chen J., and Bartsch H. (Eds). Relevance to Human Cancer of N-nitroso Compounds, Tobacco Smoke and Mechanisms, IARC Scientific Publications No. 105 (1991), International Agency for Research on Cancer, Lyon, France 579-583
222. Committee on Nitrite and Alternative Curing Agents in Food, Assembly of Life Sciences 1981. The health effect of nitrate, nitrite and N-nitroso compounds, Part 1 of a two-part study, National Academy Press, Washington, DC, pp. 9-43.
223. Ahotupa M., Bereziat J.C., Bussacchini-Griot V., Camus A.M., and Bartsch H. Lipid peroxidation induces by N-nitrosodimethylamine (NDMA) in rats in vivo and in isolated hepatocytes. Free Radic. Res. Commun. 3 (1987) 285-291
224. Ahotupa M., Bussacchini-Griot V., Bereziat J.C., Camus A.M., and Bartsch H. Rapid oxidative stress induced by N-nitrosamines. Biochem. Biophys. Res. Commun. 146 (1987) 1047-1054
225. Bartsch H., Hietanen E., and Malaveille C. Carcinogenic nitrosamines: free radical aspects of their action. Free Radic. Biol. Med. 7 (1989) 637-644
226. Habs M., and Schmahl D. Synergistic effects of N-nitroso compounds in experimental long-term carcinogenesis studies. Oncology 37 (1980) 259-265
227. Lijinsly W. N-Nitrosocompounds in the diet. Mutat. Res. 443 (1999) 129-138
228. Rowland L.R., Granli T., Bøckman O.C., Key P.E., and Massey R.C. Endogenous N-nitrosation in man assessed by measurement of apparent total N-nitroso compounds in faeces. Carcinogenesis 12 (1991) 1395-1401
229. Nielsen J.B., and Lings S. Nitrosamines formation via non-prescription drugs?. Med. Hypotheses 42 (1994) 265-268